Sarepta Therapeutics

About:

Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.

Twitter/X: sarepta

Top Investors: MidCap Financial, Pharmakon Advisors, Roche Financial, Michael Andrew Chambers

Description:

Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$1.39B

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

1980-01-01

Contact Email:

sarepta(AT)sareptatherapeutics.com

Founders:

James Summerton, Marwan Fawaz